PROFILE: EMA pharmacovigilance chief June Raine on how to improve risk management and inspiring women
This article was originally published in SRA
Executive Summary
June Raine is the first ever chair of the European Medicines Agency's Pharmacovigilance Risk Assessment Committee, which oversees the risk management of your medicines. Dr Raine is also director of vigilance and risk management at MHRA, the UK regulator, as well as a member of the World Health Organization advisory committee on the safety of medicinal products. She talked to Francesca Bruce* about her passion for public health, preventing drug crises, and dancing to ABBA.